Why Twist Bioscience Corp’s (TWST) Stock Is Down 8.86%

By AAII Staff
February 13, 2024
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Twist Bioscience Corp before investing.

In this article, we go over a few key elements for understanding Twist Bioscience Corp’s stock price such as:

  • Twist Bioscience Corp’s current stock price and volume
  • Why Twist Bioscience Corp’s stock price changed recently
  • Upgrades and downgrades for TWST from analysts
  • TWST’s stock price momentum as measured by its relative strength

About Twist Bioscience Corp (TWST)

Before we jump into Twist Bioscience Corp’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.

Want to learn more about Twist Bioscience Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Twist Bioscience Corp.

Learn More About A+ Investor

Twist Bioscience Corp’s Stock Price as of Market Close

As of February 13, 2024, 4:00 PM, CST, Twist Bioscience Corp’s stock price was $37.01.

Twist Bioscience Corp is down 8.86% from its previous closing price of $40.61.

During the last market session, Twist Bioscience Corp’s stock traded between $37.52 and $40.83. Currently, there are 57.50 million shares of Twist Bioscience Corp stock available for purchase.

Unfortunately, Twist Bioscience Corp’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Twist Bioscience Corp Stock Price History

Twist Bioscience Corp’s (TWST) price is currently up 14.23% so far this month.

During the month of February, Twist Bioscience Corp’s stock price has reached a high of $40.83 and a low of $32.27.

Over the last year, Twist Bioscience Corp has hit prices as high as $40.83 and as low as $11.46. Year to date, Twist Bioscience Corp’s stock is up 55.44%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Twist Bioscience Corp Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 12, 2024, there were 9 analysts who downgraded Twist Bioscience Corp’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Twist Bioscience Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Twist Bioscience Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Twist Bioscience Corp’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Twist Bioscience Corp (TWST) by visiting AAII Stock Evaluator.

Relative Price Strength of Twist Bioscience Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of February 12, 2024, Twist Bioscience Corp has a weighted four-quarter relative price strength of 44.04%, which translates to a Momentum Score of 97 and is considered to be Very Strong.

Want to learn more about how Twist Bioscience Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Twist Bioscience Corp Stock Price: Bottom Line

As of February 13, 2024, Twist Bioscience Corp’s stock price is $37.01, which is down 8.86% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Twist Bioscience Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.